• About us
  • Membership
  • Contact us
  • Wed February 11, 2026

  • Home
  • Society
  • Economy
  • Politics
  • Sports
  • Culture
  • International
  • Multimedia
  • Tourism

Epidermolysis bullosa

Total:2

  • No lack of medical supplies for EB despite sanctions 2024-12-29 17:01

    No lack of medical supplies for EB despite sanctions

    TEHRAN –Despite sanctions, Iran’s Food and Drug Administration (IFDA) has managed to procure and store the essential medical supplies needed by Epidermolysis Bullosa (EB) patients, an official with IFDA has said.

  • Iran achieves technology to manufacture dressings for EB patients 2024-01-09 15:25

    Iran achieves technology to manufacture dressings for EB patients

    TEHRAN –An Iranian knowledge-based company has gained the technology for producing wound dressings for Epidermolysis Bullosa (EB) patients.

All Pages

Latest

  • 15267

  • Judiciary chief says convicts involved in the January riots won’t be amnestied

  • Over 140 rioters involved in recent unrest nabbed

  • Transferring uranium outside Iran not on agenda of Oman talks: nuclear chief 

  • Epstein files, war calculations, and the deeper conflict with Iran

  • America is putting a brave face on defeat

  • Iran to unveil its first radar satellite soon

  • FM, military chief brief parliament on nuclear talks, defense capabilities 

  • Trump, Greenland, and the fracturing of globalization

  • Pezeshkian says Oman-mediated talks offer fair solution if US shows respect

  • ‘Pizza,’ power, and the pedophile blueprint

  • Ayatollah Khamenei: Iranians to affirm loyalty to Islamic Republic on Bahman 22

  • 47 years of resistance

  • Egyptian supporters of the Islamic Republic

  • Ivan Illich’s “Tools for Conviviality” published in Persian

Desktop version Mobile version
Top
  • About us
  • Membership
  • Contact us
  • Home
  • Society
  • Economy
  • Politics
  • Sports
  • Culture
  • International
  • Multimedia
  • Tourism

All Content by Mehr News Agency is licensed under a Creative Commons Attribution 4.0 International License.

Developed by: Nastooh Designed by: Pixel Studio